VistaGen Therapeutics, Inc. (NASDAQ:VTGN) Q3 2023 Earnings Call Transcript
Operator: Greetings. Welcome to VistaGen Therapeutics Third Quarter Fiscal Year 2023 Results Conference Call. At this time all participants are in a listen-only mode.
Stay updated with breaking news from One Mind. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Operator: Greetings. Welcome to VistaGen Therapeutics Third Quarter Fiscal Year 2023 Results Conference Call. At this time all participants are in a listen-only mode.
Harvey Schwartz takes over at private equity behemoth Carlyle Group on February 15.
Harvey Schwartz is set to lead the alternatives giant.
Premature deaths are not inevitable, and treatment is getting better for service members and veterans with the signature wounds of the post-9/11 era, experts say.
At the third 'No Money for Terror' Ministerial Conference hosted by New Delhi, India offered to house a permanent secretariat to sustain the continued global focus to disrupt the 'money trail' that makes terror outfits survive.